Not Tagged
astrazeneca,gsk
['$azn', '$gsk']
$xbi #asco2022 $gsk $azn these mainstream headlines on potentially practice changing data revealed at asco could portend a continuing change in tide of biopharma sentiment, and one hopes, investment dollars (patient outcome improvement is always #1): 
“The fault, dear Brutus, lies not within the stars, but in ourselves, that we are underlings.”